Cancer Executives Feature
Guideway’s Care Guidance Program Featured in the Association of Cancer Executives (ACE) Newsletter


Guideway Care’s groundbreaking Care guidance program has garnered significant attention in the healthcare community, earning a featured spot in the August issue of the Association of Cancer Executives (ACE) Newsletter. This spotlight highlights the program’s revolutionary approach to advancing health equity and improving patient outcomes, particularly in the context of cancer care. Let’s delve into the key insights presented in this influential piece.
In a joint effort by Edward Partridge, MD, Chief Medical Officer at Guideway Care, and Warren Smedley, DSc, MSHA, MSHQS, Vice President at The Kinetix Group, the article delves into the critical role that Guideway Care’s Care guidance program plays in addressing health disparities and ensuring optimal operational and financial performance in value-based care and quality payment programs.
The transition from fee-for-service to value-based care is driving the need for innovative solutions that align health equity initiatives with quality payment strategies. Cancer hospitals, in particular, are seeking avenues to participate in programs that reward improvements in outcomes and health equity. Guideway Care’s care guidance program supports this shift by identifying, addressing and resolving barriers related to social determinants of health (SDoH) and health disparities.
Social determinants of health, encompassing socioeconomic, cultural, and environmental factors, significantly impact patient outcomes, particularly in cancer care. A considerable portion of patient risk, nearly 80%, is attributed to these non-clinical factors. The presence of SDoH-related disparities can impede access to care and treatment adherence, compounding the challenges faced by cancer patients. The article sheds light on the ways Guideway Care’s care guidance program proactively works to resolve these disparities.
Guideway Care’s care guidance program introduces a human-led approach to patient care, empowering care guides to establish connections with patients and their families. This approach builds trust, enhances communication, and uncovers potential barriers to care. By focusing on the comprehensive well-being of patients, care guidance programs pave the way for better outcomes, efficient care delivery and resource optimization.
Effective collaboration between hospitals, providers, and care guides forms a powerful triad for care coordination and management. This collaborative approach enhances patient engagement, encourages shared decision-making and facilitates self-management of care. Care guidance programs also serve as a foundation for integrated care delivery systems, attracting value-based contracting entities and insurance networks.
As healthcare organizations grapple with nursing and resource shortages, care guidance programs provide an innovative solution to these challenges. By extending support services and relieving clinical staff of non-clinical responsibilities, hospitals can redirect resources toward delivering high-quality, patient-centered care.
Guideway Care’s care guidance program emerges as a game-changer in the realm of cancer care. By addressing social determinants of health and health disparities, this innovative approach empowers patient satisfaction scores, supports clinical teams, and ultimately enhances the quality of care delivered. This strategic partnership exemplifies a forward-thinking approach to health equity, operational efficiency, and patient-centric care in the ever-evolving landscape of healthcare.
Contact us to learn more about Guideway care guidance solution and its transformative impact on cancer care, we invite you to read the full article in the Association of Cancer Executives (ACE) Newsletter. The future of healthcare is being shaped by innovative solutions, and care guidance is at the forefront of this positive transformation.
We use cookies and similar technologies to improve your experience on our website. Read our Privacy Policy.